These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1187742)

  • 1. [Treatment of the DS-carcinosarcoma in the rat with ifosfamide/dimethylsulfoxide].
    von Ardenne M; Reitnauer PG
    Pharmazie; 1975 Sep; 30(9):602-5. PubMed ID: 1187742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapeutic activity of ifosfamide in 6 different isologously transplanted experimental tumours of BD-rats (author's transl)].
    Stekar J
    Arzneimittelforschung; 1976; 26(10):1793-7. PubMed ID: 191035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of ifosfamid with cyclophosphamide in the therapy of rat DS carcinosarcoma].
    von Ardenne M; Reitnauer PG; Rohde K
    Arch Geschwulstforsch; 1971; 38(1):15-26. PubMed ID: 4334130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities].
    Ardenne M; Reitnauer PG
    Arzneimittelforschung; 1975 Sep; 25(9):1369-79. PubMed ID: 22
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic experiments with spores of strain Clostridium butyricum and Cyclophosphamide in Jensen sarcoma, Walker carcinoma, and DS carcinosarcoma of the rat (author's transl)].
    Kretschmer H; Ludewig R; Hambsch K
    Arch Geschwulstforsch; 1974; 44(1):65-9. PubMed ID: 4447441
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
    Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
    Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of immune reactions on the radiosensitivity of DS-carcinosarcoma in the rat].
    Rotte K
    Strahlentherapie; 1973 Apr; 145(4):474-86. PubMed ID: 4704370
    [No Abstract]   [Full Text] [Related]  

  • 9. [The time lapse of the cytostatic effect of ifosfamide].
    von Ardenne M; Reitnauer PG
    Onkologie; 1978 Aug; 1(4):165-70. PubMed ID: 30929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 11. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
    Takamizawa A; Iwata T; Yamaguchi K; Shiratori O; Harada M
    Cancer Treat Rep; 1976 Apr; 60(4):361-8. PubMed ID: 1277212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACPA (1-aminocyclopentanol-1-carboxylic acid) as an antitumor agent].
    Minenkova EA; Vermel' EM
    Vopr Onkol; 1967; 13(2):93-9. PubMed ID: 5245210
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ifosfamide in the treatment of solid tumors and their metastases].
    Wicart L
    Nouv Presse Med; 1976 Apr; 5(15):996-8. PubMed ID: 778786
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of dimethyl sulfoxide in medicine and biology (a review of the literature)].
    Budennaia MP
    Vrach Delo; 1983 Nov; (11):6-12. PubMed ID: 6362197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
    Miuller NR; Remizov AL; Belogorodskiĭ VV; Filov VA
    Farmakol Toksikol; 1975; 38(5):590-1. PubMed ID: 1191387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].
    Brock N; Stekar J; Pohl J
    Naturwissenschaften; 1979 Jan; 66(1):60-1. PubMed ID: 106307
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dimethylsulfoxide, solvent and medicament].
    Selmiciu I; Oiţă N; Dumitrache M
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(1):7-11. PubMed ID: 5438936
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M; Kuśnierczyk H; Budzyński W; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):275-84. PubMed ID: 3592931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.